** Proteomics International Laboratories PIQ.AX jumps as much as 9.5% to A$0.810, highest since Oct. 11
** Medical technology firm says its OxiDx test - a finger-prick blood test to measure oxidative stress - accurately identifies muscle damage in marathon runners
** PIQ sets sights on H1 CY25 for Australian commercial launch of OxiDx test
** More than 540,000 shares traded, 5x the 30-day avg
** Stock trims YTD losses to 12.3%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))